Q4 2025 Management View CEO Darryll Dewan highlighted that TSS delivered a very strong fourth quarter, capping what he called a "transformational 2025" for the company. Dewan stated, "In the fourth ...

Nomad Foods has revised its revenue and adjusted EBITDA forecasts for 2025, citing weaker-than-expected first-half results. Announcing the frozen-food group’s second-quarter results, CEO Stéfan ...

Adjusted EBITDA is intended to provide a true picture of a company’s earnings. In M&A deals, companies will often strip out or add back one-time, non-cash expenses, such as restructuring costs, ...

Q4 2025 Management View CEO Hervé Sedky opened by highlighting 2025 as a “transformational year,” pointing to “solid year-on-year growth in revenue and adjusted EBITDA, excluding insurance proceeds of ...

Strata Critical Medical rated Buy with 30–35% upside over 12–24 months. SRTA stock trades at a 53% EV/EBITDA discount to peer ...

Parsons reported $6.4 billion in revenue for fiscal year 2025, while achieving record adjusted EBITDA and net income for the full year. How Did Parsons Perform Financially in Fiscal Year 2025? In an ...

There is nothing wrong with EBITDA—it's a means of measuring profitability. The problem is that it does not give you a ...

Adjusted EBITDA margin* stood at 21.2% up 200 bps compared to 19.2% in Q4 2024. Revenue was $913.5M, up $45.8M or 5.3%. Accessibility growth of 5.4% including growth of 7.4% in North America and 2.3% ...